STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #810 by analyst upside · 2026-08-13
KRMD
KORU Medical Systems, Inc.
Healthcare · Market Cap $152M · P/E 0x
ANALYST PRICE TARGET
+100.0%
implied upside to consensus target
Current Price $3.3
Consensus Target $6.6
Bull Target $8.0
Bear Target $5.0
Analysts Covering 5
ANALYST CONSENSUS - BUY
Strong Buy
0
Buy
4
Hold
1
Sell
0
52-Week Low $3.21
52-Week High $6.61
YTD Return -41.2%
FUNDAMENTALS
Market Cap $152M
P/E Ratio (TTM) N/A
Forward P/E 94.3x
EPS (TTM) $-0.04
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $45M
Profit Margin -4.0%
52-WEEK RANGE
52-Week Low $3.21
52-Week High $6.61
Current Price $3.3
Bear Target $5.0
Bull Target $8.0
● Now $3.3 ● Target $6.6
TRADING DATA
Avg Volume 160K
YTD Return -41.2%
Analyst Count 5
Consensus Buy
Upside to Target +100.0%
Last Updated 2026-08-13

ANALYST SUMMARY

KORU Medical Systems, Inc. (KRMD) is currently trading at $3.3 with a Wall Street consensus price target of $6.6, implying potential upside of 100.0% over the next 12 months. 5 analysts currently cover KRMD, with a consensus rating of Buy - 80% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.0, while the most cautious has a target of $5.0.

KRMD operates in the Healthcare sector with a market capitalisation of $152M. The stock is down 41.2% year-to-date and is currently trading near the lower end of its 52-week range of $3.21 – $6.61.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for KRMD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Canaccord Genuity - Reiterated
Buy → Buy 2026-03-13 Building track record
B. Riley Securities - Reiterated
Buy → Buy 2026-03-13 17% win rate (6 calls)
Lake Street - Reiterated
Buy → Buy 2025-12-22 27% win rate (11 calls)
Canaccord Genuity - Reiterated
Buy → Buy 2025-12-17 Building track record
Piper Sandler - Reiterated
Neutral → Neutral 2025-08-07 14% win rate (7 calls)
Piper Sandler - Reiterated
Neutral → Neutral 2025-05-08 14% win rate (7 calls)
Piper Sandler ↓ Downgrade
Overweight → Neutral 2025-02-14 14% win rate (7 calls)
Craig-Hallum - Reiterated
Buy → Buy 2025-01-17 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
48
out of 100
Coverage depth
14/30
Consensus clarity
12/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →